CAIHF: AI 评分 53/100 — AI 分析 (4月 2026)

Chia Tai Enterprises International Limited operates in the biochemical and industrial sectors, manufacturing chlortetracycline (CTC) products and engaging in machinery equipment sales and services. The company serves markets across Mainland China, Asia Pacific, the Americas, and Europe.

Key Facts: AI Score: 53/100 Sector: Healthcare

公司概况

概要：

Chia Tai Enterprises International Limited, a subsidiary of Charoen Pokphand Foods, manufactures and sells chlortetracycline (CTC) products globally under the Shihao and Citifac brands, alongside its industrial segment focused on machinery equipment and automotive parts, primarily operating within Mainland China and the Asia Pacific region.

CAIHF是做什么的？

Chia Tai Enterprises International Limited, established in 1987 and based in Hong Kong, operates as a diversified entity with a focus on both biochemical and industrial sectors. The company's biochemical segment is dedicated to the production and distribution of chlortetracycline (CTC) premix and hydrochloride products. These products are marketed under the Shihao and Citifac brands and are primarily used as feed additives in the livestock industry to promote growth, prevent diseases, and enhance feed efficiency. The company distributes these products across Mainland China, the Asia Pacific, the Americas, and Europe. In addition to its biochemical operations, Chia Tai Enterprises engages in industrial activities involving the sale, leasing, and servicing of Caterpillar machinery equipment. This includes excavators, power generators, bulldozers, and compactors, along with the provision of spare parts. The industrial segment also manufactures and sells carburetors and automotive parts for automobile and motorcycle manufacturers. The company's operations are primarily concentrated in Mainland China. Chia Tai Enterprises International Limited is a subsidiary of Charoen Pokphand Foods Public Company Limited, a large agro-industrial and food conglomerate.

CAIHF的投资论点是什么？

Chia Tai Enterprises International Limited presents a mixed investment profile. The company's P/E ratio of 6.55 suggests a potentially undervalued stock, while a gross margin of 14.5% and a profit margin of 6.0% indicate moderate profitability. The company's beta of 4.55 indicates high volatility relative to the market. Growth catalysts include potential expansion in the animal feed additives market and increased demand for machinery in developing regions. However, risks include reliance on commodity prices for CTC production and competition in both the biochemical and industrial sectors. the may be worth researching company's financial performance, market dynamics, and risk factors before making investment decisions.

CAIHF在哪个行业运营？

Chia Tai Enterprises International Limited operates within the biotechnology and industrial sectors. The biotechnology industry, particularly the animal health segment, is driven by increasing demand for livestock products and the need for efficient feed additives. The industrial sector is influenced by infrastructure development and construction activities, especially in emerging markets. Competition is intense in both sectors, with established players and new entrants vying for market share. Chia Tai Enterprises' position is supported by its established brands and its parent company's resources.

Biotechnology

Healthcare

CAIHF有哪些增长机遇？

Expansion in the Animal Feed Additives Market: The global animal feed additives market is projected to reach $25 billion by 2028, driven by increasing demand for livestock products and the need for improved animal health. Chia Tai Enterprises can capitalize on this trend by expanding its CTC product line and distribution network, particularly in emerging markets where livestock production is growing rapidly. This expansion could significantly increase revenue and market share.
Increased Demand for Machinery in Developing Regions: Infrastructure development and construction activities in developing regions are driving demand for machinery equipment. Chia Tai Enterprises can leverage its industrial segment to capitalize on this trend by expanding its sales and leasing operations in these regions. This expansion could lead to increased revenue and profitability.
Strategic Partnerships and Acquisitions: Chia Tai Enterprises can pursue strategic partnerships and acquisitions to expand its product portfolio and geographic reach. Collaborating with other companies in the biotechnology and industrial sectors can provide access to new technologies, markets, and distribution channels. This strategy can accelerate growth and enhance competitiveness.
Product Innovation and Development: Investing in research and development to create new and improved products can drive growth and differentiate Chia Tai Enterprises from its competitors. Developing innovative CTC formulations and machinery equipment can attract new customers and increase market share. This strategy requires ongoing investment and a focus on customer needs.
Enhancing Operational Efficiency: Improving operational efficiency can reduce costs and increase profitability. Chia Tai Enterprises can implement lean manufacturing principles, optimize its supply chain, and automate processes to improve efficiency. This strategy can enhance competitiveness and improve financial performance.

P/E ratio of 6.55, suggesting potential undervaluation compared to industry peers.
Gross margin of 14.5%, reflecting moderate efficiency in production and sales.
Profit margin of 6.0%, indicating average profitability within the biotechnology sector.
Beta of 4.55, signaling high volatility compared to the overall market.
Operates in two segments: Biochemical (CTC products) and Industrial (machinery equipment).

CAIHF提供哪些产品和服务？

Manufactures and sells chlortetracycline (CTC) premix and hydrochloride products.
Markets CTC products under the Shihao and Citifac brands.
Provides feed additives for livestock to promote growth and prevent diseases.
Engages in the sale, leasing, and servicing of Caterpillar machinery equipment.
Offers excavators, power generators, bulldozers, and compactors.
Sells spare parts for machinery equipment.
Manufactures and sells carburetors and automotive parts.

CAIHF如何赚钱？

Generates revenue from the sale of CTC premix and hydrochloride products.
Derives income from the sale, leasing, and servicing of machinery equipment.
Earns revenue from the sale of spare parts and automotive parts.

Livestock farmers and feed manufacturers who use CTC products as feed additives.
Construction companies and infrastructure developers who purchase or lease machinery equipment.
Automobile and motorcycle manufacturers who use carburetors and automotive parts.

Established brands (Shihao and Citifac) in the animal feed additives market.
Distribution network in Mainland China, Asia Pacific, the Americas, and Europe.
Relationship with parent company Charoen Pokphand Foods Public Company Limited.
Expertise in manufacturing CTC products and machinery equipment.

什么因素可能推动CAIHF股价上涨？

Upcoming: Potential expansion in the animal feed additives market, driven by increasing demand for livestock products.
Upcoming: Increased infrastructure development in emerging markets, boosting demand for machinery equipment.
Ongoing: Strategic partnerships and acquisitions to expand product portfolio and geographic reach.
Ongoing: Product innovation and development to create new and improved CTC formulations and machinery equipment.
Ongoing: Efforts to enhance operational efficiency to reduce costs and increase profitability.

CAIHF的主要风险是什么？

Potential: Fluctuations in commodity prices affecting CTC production costs.
Potential: Changes in government regulations impacting the biotechnology and industrial sectors.
Potential: Economic downturns in key markets reducing demand for products and services.
Potential: Technological advancements by competitors leading to loss of market share.
Ongoing: Competition in both the biochemical and industrial sectors.

CAIHF的核心优势是什么？

Established brands in the animal feed additives market.
Distribution network in multiple regions.
Relationship with parent company Charoen Pokphand Foods.
Diversified operations in biochemical and industrial sectors.

CAIHF的劣势是什么？

Reliance on commodity prices for CTC production.
Competition in both biochemical and industrial sectors.
Limited financial information available due to OTC listing.
High beta indicates significant volatility.

CAIHF有哪些机遇？

Expansion in the animal feed additives market.
Increased demand for machinery in developing regions.
Strategic partnerships and acquisitions.
Product innovation and development.

CAIHF面临哪些威胁？

Fluctuations in commodity prices.
Changes in government regulations.
Economic downturns in key markets.
Technological advancements by competitors.

CAIHF的竞争对手是谁？

Biocept Inc — Focuses on oncology diagnostics. — (BICTF)
Biora Therapeutics Inc — Develops targeted therapeutics. — (BIOR)
Bionomics Ltd — Specializes in CNS disorders. — (BMNDF)
Enzolytics Inc — Develops anti-viral therapeutics. — (ENZC)
Evofem Biosciences Inc — Focuses on women's health products. — (EVFM)

Key Metrics

MoonshotScore: 53/100

Company Profile

CEO: Chawalit Na Muangtoun
Headquarters: Central, HK
Employees: 900
Founded: 2023

AI Insight

AI analysis pending for CAIHF

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Chia Tai Enterprises International Limited do?

Chia Tai Enterprises International Limited operates in two primary segments: biochemical and industrial. In the biochemical segment, the company manufactures and sells chlortetracycline (CTC) premix and hydrochloride products, marketed under the Shihao and Citifac brands. These products are used as feed additives in the livestock industry to promote growth, prevent diseases, and enhance feed efficiency. The industrial segment focuses on the sale, leasing, and servicing of Caterpillar machinery equipment, including excavators, power generators, bulldozers, and compactors, as well as the manufacture and sale of carburetors and automotive parts.

What do analysts say about CAIHF stock?

There is currently no available analyst coverage or consensus for CAIHF stock due to its listing on the OTC Other tier and limited financial disclosure. Key valuation metrics such as price targets and earnings estimates are not available. Investors should conduct their own due diligence and consider the company's financial performance, market dynamics, and risk factors before making investment decisions. The lack of analyst coverage increases the risk associated with investing in CAIHF.

What are the main risks for CAIHF?

Chia Tai Enterprises International Limited faces several risks, including fluctuations in commodity prices affecting CTC production costs, changes in government regulations impacting the biotechnology and industrial sectors, economic downturns in key markets reducing demand for products and services, and technological advancements by competitors leading to loss of market share. Additionally, the company's listing on the OTC Other tier presents risks related to limited financial disclosure, lower liquidity, and less regulatory oversight.